Armstrong Fleming & Moore Inc purchased a new position in Procter & Gamble Company (The) (NYSE:PG - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 11,888 shares of the company's stock, valued at approximately $1,894,000. Procter & Gamble accounts for about 1.0% of Armstrong Fleming & Moore Inc's investment portfolio, making the stock its 17th biggest position.
A number of other institutional investors have also added to or reduced their stakes in PG. Nova Wealth Management Inc. purchased a new stake in shares of Procter & Gamble during the first quarter worth about $26,000. Signature Resources Capital Management LLC boosted its holdings in shares of Procter & Gamble by 67.9% during the second quarter. Signature Resources Capital Management LLC now owns 178 shares of the company's stock worth $28,000 after purchasing an additional 72 shares during the period. Quarry LP bought a new position in Procter & Gamble in the first quarter worth about $33,000. Mizuho Securities Co. Ltd. raised its stake in Procter & Gamble by 566.7% in the first quarter. Mizuho Securities Co. Ltd. now owns 200 shares of the company's stock worth $34,000 after buying an additional 170 shares in the last quarter. Finally, RMG Wealth Management LLC bought a new position in shares of Procter & Gamble during the second quarter valued at approximately $37,000. Institutional investors own 65.77% of the company's stock.
Analyst Upgrades and Downgrades
PG has been the subject of a number of analyst reports. Evercore ISI reaffirmed an "in-line" rating and set a $170.00 target price (down previously from $190.00) on shares of Procter & Gamble in a research note on Monday, July 14th. BNP Paribas Exane dropped their price target on shares of Procter & Gamble from $177.00 to $172.00 and set an "outperform" rating on the stock in a research note on Tuesday, September 23rd. UBS Group cut their price objective on shares of Procter & Gamble from $180.00 to $176.00 and set a "buy" rating for the company in a research report on Wednesday. Wells Fargo & Company cut their price objective on shares of Procter & Gamble from $173.00 to $170.00 and set an "overweight" rating for the company in a research report on Thursday, September 25th. Finally, Weiss Ratings reaffirmed a "hold (c+)" rating on shares of Procter & Gamble in a report on Wednesday. Eleven research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $172.58.
Check Out Our Latest Stock Analysis on Procter & Gamble
Insiders Place Their Bets
In other news, insider Balaji Purushothaman sold 490 shares of Procter & Gamble stock in a transaction dated Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total value of $74,592.70. Following the sale, the insider owned 12,616 shares in the company, valued at $1,920,533.68. This trade represents a 3.74% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, COO Shailesh Jejurikar sold 3,986 shares of the firm's stock in a transaction dated Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total transaction of $606,788.78. Following the completion of the transaction, the chief operating officer directly owned 46,899 shares in the company, valued at approximately $7,139,434.77. This represents a 7.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 149,763 shares of company stock valued at $23,421,279. 0.20% of the stock is owned by company insiders.
Procter & Gamble Price Performance
Shares of PG stock opened at $150.67 on Thursday. The company's 50-day simple moving average is $155.26 and its two-hundred day simple moving average is $159.72. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.70 and a quick ratio of 0.49. The company has a market capitalization of $352.64 billion, a P/E ratio of 23.14, a P/E/G ratio of 4.05 and a beta of 0.36. Procter & Gamble Company has a one year low of $149.91 and a one year high of $180.43.
Procter & Gamble (NYSE:PG - Get Free Report) last posted its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.42 by $0.06. The business had revenue of $20.89 billion during the quarter, compared to analysts' expectations of $20.79 billion. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The business's quarterly revenue was up 1.7% on a year-over-year basis. During the same quarter last year, the company posted $1.40 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, equities analysts anticipate that Procter & Gamble Company will post 6.91 EPS for the current year.
Procter & Gamble Company Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.